Skip to content

Bilateral Ultrasound Guided Quadratus Lumborum Versus Lumbar Epidural Block on Postoperative Analgesia, and Inflammatory Response in Abdominal Surgery

Effect of Bilateral Ultrasound Guided Quadratus Lumborum Block Versus Lumbar Epidural Block on Postoperative Analgesia, and Inflammatory Response Following Major Lower Abdominal Cancer Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03958942
Enrollment
60
Registered
2019-05-22
Start date
2019-06-01
Completion date
2020-03-01
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Response, Postoperative Pain

Brief summary

This study aims at comparing the effects of bilateral ultrasound-guided quadratus lumborum block versus lumbar epidural block on postoperative analgesia and inflammatory response following major lower abdominal cancer surgery.

Interventions

OTHERUltrasound quadratus lumborum block with bupivacaine 25%

echogenic needle will be inserted in-plane with the ultrasound beam in a posterior-to-anterior direction through the quadratus lumborum muscle until the ventral fascia of the muscle penetrated. At this point, the needle directed toward the fascial plan between the quadratus lumborum and the Psoas muscle

OTHERlumbar epideural block with bupivacaine 25%

lumbar epidural will be performed for patients in group II using a 16-gauge Touhy epidural needle by a median approach. The T12 - L1 or L1 - L2 interspaces will be chosen for the injection. The epidural space identified by the loss of resistance technique.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* ASA II, III * Weight 50 - 85 kg. * Scheduled for major lower abdominal cancer surgery (radical cystectomy, total abdominal hysterectomy).

Exclusion criteria

* Patients with a history of relevant drug allergy. * Coagulation disorders. * Opioid dependence. * Sepsis. * Local infection at the vicinity of the block site. * Patients with psychiatric illnesses that would interfere with perception and assessment of pain

Design outcomes

Primary

MeasureTime frameDescription
postoperative painfirst 24 hours postoperativelypostoperative pain intensity.

Secondary

MeasureTime frameDescription
postoperative inflammatory responsefirst 24 hours postoperativelyinflammatory response represented by the levels of: interleukins 1,6, and tumor necrosis factor alpha
side effectsfirst 24 hours postoperativelysedation, nausea, vomiting, and respiratory depression

Countries

Egypt

Contacts

Primary ContactAhmad M Abd El-Rahman, M.D.
ahmad23679@gmail.com00201149606060

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026